PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Electronic Screening Tool Guides Non-Geriatric Pharmacists to Intervene in Frail Inpatients

potentially inappropriate medicationsPIMspolypharmacydeprescribinggeriatric pharmacyelectronic screening toolclinical decision supporthospital pharmacistolder adultsfrailtydescriptive studyBeers CriteriaSTOPP/START Geriatrics / Geriatric Pharmacy

Background Information

New tool streamlines pharmacists' interventions for older patients' medication issues.

Older adults face high risks from polypharmacy and potentially inappropriate medications (PIMs). The tool detected 99 potential pharmacological problems in 67 patients, and 139 interventions were performed. This tool aids non-specialist pharmacists by identifying medication-related problems in older patients, streamlining interventions. A new electronic tool simplifies identification and management of medication issues in older hospitalized patients.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Flamand-Villeneuve J, Boisvert J, Blais-Lecours P, Denis C, Denis C, Méthot J

Citation: Flamand-Villeneuve J, Boisvert J, Blais-Lecours P, et al. Description of pharmaceutical interventions and clinical impacts of a new electronic tool used to identify and manage medication of vulnerable hospitalized elderly patients. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 2026;159(5):378-388. doi:10.3138/cpj-25-0124

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.